Wockhardt reports FY26 net profit of Rs 317 crore, Board approves fundraising plan
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
Subscribe To Our Newsletter & Stay Updated